Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Medicinas Complementárias
Métodos Terapéuticos y Terapias MTCI
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Cell Biol Toxicol ; 25(3): 245-51, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18465199

RESUMEN

The leukemia cell line HL60 is widely used in studies of the cell cycle, apoptosis, and adhesion mechanisms in cancer cells. We conducted a focused cytogenetic study in an HL60 cell line, by analyzing GTG-banded chromosomes before and after treatment with pisosterol (at 0.5, 1.0, and 1.8 microg/ml), a triterpene isolated from Pisolithus tinctorius, a fungus collected in the Northeast of Brazil. Before treatment, 99% of the cells showed the homogeneously staining region (HSR) 8q24 aberration. After treatment with 1.8 microg/ml pisosterol, 90% of the analyzed cells lacked this aberration. We further performed a pulse test, in which the cells treated with pisosterol (0.5, 1.0, and 1.8 microg/ml) were washed and re-incubated in the absence of pisosterol. Only 30% of the analyzed cells lacked the HSR 8q24 aberration, suggesting that pisosterol probably blocks the cells with HSRs at interphase. No effects were detected at lower concentrations. At the highest concentration examined (1.8 microg/ml), pisosterol also inhibited cell growth, but this effect was not observed in the pulse test, reinforcing our hypothesis that, at the concentrations tested, pisosterol probably does not induce cell death in the HL60 line. The results found for pisosterol were compared with those for doxorubicin. Cells that do not show a high degree of gene amplification (HSRs and double-minute chromosomes) have a less aggressive and invasive behavior and are easy targets for chemotherapy. Therefore, further studies are needed to examine the use of pisosterol in combination with conventional anti-cancer therapy.


Asunto(s)
Antineoplásicos/toxicidad , Basidiomycota/química , Ciclo Celular/efectos de los fármacos , Amplificación de Genes/efectos de los fármacos , Células HL-60/efectos de los fármacos , Leucemia Promielocítica Aguda/tratamiento farmacológico , Terpenos/toxicidad , Aberraciones Cromosómicas/efectos de los fármacos , Bandeo Cromosómico , Doxorrubicina/toxicidad , Ensayos de Selección de Medicamentos Antitumorales , Células HL-60/fisiología , Humanos , Índice Mitótico , Extractos Vegetales/toxicidad
2.
Genet. mol. res. (Online) ; 2(2): 223-228, Jun. 2003.
Artículo en Inglés | LILACS | ID: lil-417606

RESUMEN

The Canova Method (CM) is a homeopathic medicine indicated for the treatment of patients with cancer and for pathologies that involve a depressed immune system, such as AIDS. This product is composed of homeopathic dilutions of Aconitum napellus, Arsenicum album (arsenic trioxide), Bryonia alba, Lachesis muta venom and Thuya occidentalis. It stimulates the immune system by activating macrophages. Activated macrophages stimulate the lymphocytes so that they increase their cytotoxic action in response to tumoral growth or infection. Given that the CM stimulates and accelerates the activity of macrophages and lymphocytes, we evaluated genotoxic effects induced in human lymphocytes treated with this homeopathic medication in vitro. Structural and numerical chromosomal aberrations were scored for the assessment of induced genotoxic effects, while the variation in mitotic index was considered as a monitor for induced cellular toxicity. The lymphocytes were cultivated for 24, 48 or 72 h in the following final concentrations of the medicinal composite CM: 4, 8 and 12. Treatments with the CM did not affect mitotic indexes, nor did they provoke chromosomal aberrations, when compared with untreated controls. There was no cytotoxicity or genotoxicity at the chromosomal level


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Antineoplásicos/toxicidad , Homeopatía , Técnicas In Vitro , Linfocitos/efectos de los fármacos , Aberraciones Cromosómicas , Análisis Citogenético , Extractos Vegetales/toxicidad , Linfocitos/citología , Índice Mitótico , Pruebas de Mutagenicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA